A three‐miRNA‐based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1‐RUNX1T1 acute myeloid leukaemia.

MLA

Zampini, Matteo, et al. “A Three‐miRNA‐based Expression Signature at Diagnosis Can Predict Occurrence of Relapse in Children with t(8;21) RUNX1‐RUNX1T1 Acute Myeloid Leukaemia.” British Journal of Haematology, vol. 183, no. 2, Oct. 2018, pp. 298–301. EBSCOhost, https://doi.org/10.1111/bjh.14950.

APA

Zampini, M., Bisio, V., Leszl, A., Putti, M. C., Menna, G., Rizzari, C., Pession, A., Locatelli, F., Basso, G., Tregnago, C., & Pigazzi, M. (2018). A three‐miRNA‐based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1‐RUNX1T1 acute myeloid leukaemia. British Journal of Haematology, 183(2), 298–301. https://doi.org/10.1111/bjh.14950

Chicago

Zampini, Matteo, Valeria Bisio, Anna Leszl, Maria C. Putti, Giuseppe Menna, Carmelo Rizzari, Andrea Pession, et al. 2018. “A Three‐miRNA‐based Expression Signature at Diagnosis Can Predict Occurrence of Relapse in Children with t(8;21) RUNX1‐RUNX1T1 Acute Myeloid Leukaemia.” British Journal of Haematology 183 (2): 298–301. doi:10.1111/bjh.14950.